cytarabine has been researched along with Female Genital Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, AK; Azodi, M; Hui, P; Litkouhi, B; McCarthy, S; Ratner, E; Rutherford, T; Schwartz, PE; Xu, ML | 1 |
| Atkins, JN; Capizzi, RL; Caponera, ME; Craig, JB; Jackson, DV; Muss, HB; Powell, BL; Richards, F; White, DR; Zekan, PJ | 1 |
2 other study(ies) available for cytarabine and Female Genital Neoplasms
| Article | Year |
|---|---|
Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Female; Genital Neoplasms, Female; Gynecologic Surgical Procedures; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisolone; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Retrospective Studies; Survival Analysis; Teniposide; Vincristine; Young Adult | 2014 |
Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Cytarabine; Drug Evaluation; Etoposide; Female; Genital Neoplasms, Female; Head and Neck Neoplasms; Hematologic Diseases; Humans; Kidney Neoplasms; Lymphoma, Non-Hodgkin; Middle Aged | 1987 |